Postdates Antepartum Testing and a Nonreactive NST at 41 Weeks
A 29-year-old G2P1 at 41 weeks 0 days comes for an antenatal visit. Her pregnancy has been uncomplicated except for diet-controlled gestational diabetes. She reports good fetal movement. Blood pressure is 122/78, fundal height 37 cm, and the fetal heart rate is 140 bpm by Doppler. The office has a monitor, and the nurse performs a 20-minute NST. The tracing shows a baseline of 145 bpm, moderate variability, no decelerations, and one acceleration of 16 bpm lasting 12 seconds at 14 minutes. The provider is seeing other patients and says, "Just repeat it next week if it's nonreactive." The patient asks whether she needs to be induced.
1. Interpret the NST result and explain the appropriate next step rather than repeating in a week.
Read the worked answer
The NST is nonreactive by standard criteria: two accelerations of at least 15 bpm lasting at least 15 seconds within 20 minutes are required, and this strip has one acceleration of 16 bpm lasting only 12 seconds. Moderate variability and no decelerations are reassuring features, but they do not make the test reactive.
The appropriate next step is not to wait a week. At 41 weeks with gestational diabetes, the risk of placental insufficiency and stillbirth rises, and antenatal testing is used to identify fetal compromise. Options include extending the monitoring period (many protocols allow up to 40 minutes or a vibroacoustic stimulation), performing a biophysical profile, or proceeding to further evaluation per provider order. The provider should be informed of the nonreactive result and the plan clarified.
Waiting a week would delay evaluation of a nonreactive test in a postdates patient with a risk factor, which is not consistent with standard antenatal surveillance. The patient's question about induction is reasonable and should be addressed by the provider with a discussion of risks and benefits at 41 weeks.
2. How would you communicate this to the provider and the patient, and what would you document?
Read the worked answer
To the provider: use a structured report - gestational age, indication for testing, baseline, variability, accelerations (one at 16 bpm for 12 seconds), absence of decelerations, duration of monitoring, and the nonreactive result. Request a plan: extend monitoring, vibroacoustic stimulation, biophysical profile, or delivery planning. If the provider is unavailable, escalate per policy.
To the patient: explain that the test did not meet the criteria for reactive, that this does not necessarily mean the baby is in trouble, and that further testing or a plan is needed today rather than next week. Address her induction question honestly: at 41 weeks with gestational diabetes, delivery planning is a provider discussion, and you will help arrange it.
Document the tracing description, the nonreactive result, the time and content of the provider notification, the orders received, patient education, and the patient's questions and response. If testing is deferred, document the rationale and the plan for follow-up. Accurate documentation and closed-loop communication protect the patient and support continuity of care.